Breztri is an inhaled triple-combination therapy approved for the treatment of chronic obstructive pulmonary disease
Over the last 24 years, the company's sales has grown from Rs. 478 crores to Rs. 19,022 crores
30th Lab in Thyrocare’s expanding network to bring advanced, affordable diagnostics in Bihar and beyond
This significant milestone enhances our global regulatory standing
The FDA issued Form 483 with one observation related to building and facility management
Phesgo label expansion delivers on patients’ preference for at-home administration and is an important step in freeing up cancer care capacity in clinical settings
The transaction structured as share swap, is valued at ~Rs. 849 crore, with no cash outflow
This partnership marks a significant milestone in Sigachi's strategy to expand into advanced drug delivery technologies.
Alembic Pharmaceuticals commissions new facility at Pithampur
Priced at just Rs. 499 for 1-year supply, this initiative is aligned with the vision of Health for All
Subscribe To Our Newsletter & Stay Updated
